| Is there a generic version of Briviact? |
As of 2026, the FDA has not approved a generic version of Brivaracetam in the United States. In many other countries, however, generics have entered the market. |
| Which countries have generic Brivaracetam available? |
• India – “Brivaracetam” tablets are sold by manufacturers such as Zydus Cadila, Glenmark, and Cipla.
• Mexico – Generic tablets are available from Grupo Farmasé and Dava.
• Brazil – Generics are offered by Aché, Eurofarma, and Rangel.
• Europe (EU‑28) – Several manufacturers (e.g., Bristol Myers Squibb, Pfizer, and Sanofi under license) supply generic brivaracetam under various trade names.
• Australia – Generic versions are stocked by Pharmacies and the Pharmaceutical Benefits Scheme (PBS).
• Other regions (China, Russia, Turkey, etc.) – Brivaracetam generics are on the market, though availability may vary by local regulatory approval. |
| Do generic and brand‑name tablets contain the same active ingredient? |
Yes. Both contain brivaracetam as the active pharmaceutical ingredient (API) at the same dosage strengths (e.g., 10 mg, 20 mg, 40 mg, 80 mg). The only difference is the inactive excipients (binders, fillers, dyes) and the packaging. The efficacy, safety profile, and pharmacokinetics are expected to be bioequivalent. |
| Are there any differences in side‑effect profile? |
No. Because generics must demonstrate bioequivalence, their side‑effect profile should match that of the brand product. Common side‑effects (e.g., dizziness, somnolence, fatigue, nausea) are identical. Reported adverse events are usually similar in frequency and severity. |
| What about cost? |
Generic Brivaracetam is typically 30–70 % cheaper than the brand name (Briviact®). Exact savings depend on local pricing, pharmacy discounts, and insurance coverage. In the U.S., without a generic, patients rely on brand‑name pricing or manufacturer coupons; once a generic becomes available, most insurance plans will cover the cheaper option, sometimes with a lower or no copay. |
| How to verify that a generic is truly equivalent? |
• Check the FDA’s “Generic Drug Database” for US approvals.
• For other jurisdictions, look for approval from the EMA (European Medicines Agency), MHRA (UK), TGA (Australia), or FDA‑India.
• Ensure the packaging includes a certification of bioequivalence. |
| What if I am in the US and need a generic? |
1. Ask your prescriber – They can prescribe a generic if one is approved.
2. Check with your pharmacist – They can verify whether a generic is available and whether your insurance will cover it.
3. Manufacturer coupons – For the brand name, Pfizer (the brand holder) often offers coupons or savings cards that reduce out‑of‑pocket costs. |
| Will generic availability affect my treatment plan? |
No. Switching from brand to generic (or vice versa) should not affect efficacy or safety. It’s essential to continue taking the medication exactly as prescribed and to inform your prescriber of any switch so they can monitor your seizure control. |
| Any other key points? |
• Generic versions are produced under strict Good Manufacturing Practice (GMP) standards.
• Regulatory agencies require rigorous testing (pharmacokinetics, dissolution, stability) before approval.
• If you’re concerned about a specific generic’s quality, you can ask your pharmacist for the manufacturer’s name and approval details.
• If you experience any new or worsening side‑effects after switching, contact your prescriber promptly. |